Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
The clinical perspective on malignancies in renal transplanted patients
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för kirurgiska vetenskaper, Transplantationskirurgi.
2016 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Post-transplant malignancies cause significant morbidity and mortality. In this thesis we investigated malignancies in renal transplanted patients from a clinical viewpoint. The use of regional tumour registries considerably improved identification of pre- and post-transplant malignancies, which are generally underreported in transplant registries.

Despite previously adequate cancer treatments with favourable prognosis, patients with pre-transplant malignancies showed higher incidence of post-transplant cancer and reduced survival compared to a 1:3 ratio matched control group of patients without a previous cancer from the Collaborative Transplant Study in Europe. A careful oncological surveillance pre-transplant and post-transplant is recommended.

A multidisciplinary team evaluated the immunosuppressive and oncological treatment in a clinical prospective observational study of 120 renal transplanted patients with post-transplant malignancies. In two-thirds of the patients immunosuppression was possible to change to mTOR inhibitors with anti-tumour effects. Oncological treatment was adjusted in 50% of patients with solid or haematological tumours. MDT assessments are essential for optimizing treatment of post-transplant malignancies.

Number of previous cutaneous squamous cell carcinoma (SCC) posed the most significant risk variable in predicting subsequent SCCs during a two-years study of 73 transplanted patients with at least one SCC.

Incidence of transplant-derived tumours is 5 times higher than anticipated. Three of eleven cancers in urinary tract and two of four cancers in the transplants were transplant-derived. Five of eleven cancers of the urinary tract were BK-virus positive. Allograft immune response against these tumours offer new options for cancer treatment such as immunomodulatory or anti-viral treatment in combination with modified immunosuppression.

Ort, förlag, år, upplaga, sidor
Uppsala: Acta Universitatis Upsaliensis, 2016. , s. 82
Serie
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 1210
Nyckelord [en]
renal transplantation, malignant tumours
Nationell ämneskategori
Medicin och hälsovetenskap
Identifikatorer
URN: urn:nbn:se:uu:diva-282131ISBN: 978-91-554-9549-7 (tryckt)OAI: oai:DiVA.org:uu-282131DiVA, id: diva2:916460
Disputation
2016-06-04, Auditorium Minus, Museum Gustavianum, Akademigatan 3, Uppsala, 09:15 (Svenska)
Opponent
Handledare
Tillgänglig från: 2016-05-13 Skapad: 2016-04-02 Senast uppdaterad: 2016-06-01
Delarbeten
1. High posttransplant cancer incidence in renal transplanted patients with pretransplant cancer
Öppna denna publikation i ny flik eller fönster >>High posttransplant cancer incidence in renal transplanted patients with pretransplant cancer
Visa övriga...
2017 (Engelska)Ingår i: Transplantation, ISSN 0041-1337, E-ISSN 1534-6080, Vol. 101, nr 6, s. 1295-1302Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background. Patients with previous cancer have increasingly been accepted for renal transplantation. Posttransplant cancer risk and survival rates of these patients are unknown. Our objective was to assess the risk of posttransplant cancer in this patient group. Methods. In this retrospective, nested case-control study, we assessed the outcome of all (n = 95) renal transplanted patients with pretransplant cancer diagnoses in the Uppsala-Orebro region, Sweden. The control group was obtained from the Collaborative Transplant Study registry and included European patients without pretransplant cancer. The other control group comprised the entire renal transplanted population in Uppsala. Development of recurrent cancer, de novo cancer, and patient survival were determined. Results. Patients with pretransplant cancer showed higher incidence of posttransplant cancers and shorter survival compared with the control groups (P < 0.001). No obvious pattern in malignant diagnoses was observed. Death-censored graft survival was unaffected. Conclusions. Despite previously adequate cancer treatments and favorable prognoses, almost half of the patients experienced a posttransplant cancer. These observations do not justify abstaining from transplanting all patients with previous malignancies, because more than 50% of the patients survive 10 years posttransplantation. A careful oncological surveillance pretransplant as well as posttransplant is recommended.

Nationell ämneskategori
Medicin och hälsovetenskap
Forskningsämne
Kirurgi
Identifikatorer
urn:nbn:se:uu:diva-282111 (URN)10.1097/TP.0000000000001225 (DOI)000401835800026 ()27163539 (PubMedID)
Tillgänglig från: 2016-04-02 Skapad: 2016-04-01 Senast uppdaterad: 2017-07-04Bibliografiskt granskad
2. Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation - experiences from a prospective, clinical, observational study
Öppna denna publikation i ny flik eller fönster >>Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation - experiences from a prospective, clinical, observational study
Visa övriga...
2016 (Engelska)Ingår i: Acta Oncologica, ISSN 0284-186X, E-ISSN 1651-226X, Vol. 55, nr 6, s. 774-781Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background Solid organ transplant recipients are at increased risk of developing malignancies. The objective of this prospective, observational, one-armed study was to study the feasibility to add a mammalian target of rapamycin (mTOR) inhibitor to the immunosuppressive regimen in transplanted patients with post-transplant malignancies. During the trial the need to improve identification of post-transplant malignancies and to reassure adequate oncological treatment of these patients became evident. Multidisciplinary team (MDT) evaluation of oncological and immunosuppressive treatments was implemented for all patients with malignancies after renal or combined renal and pancreas transplantation because of the trial.Material and methods At Uppsala University Hospital, Sweden, a MDT consisting of transplant surgeons, nephrologists, oncologists and dermatologists evaluated 120 renal or combined renal and pancreas-transplanted recipients diagnosed with malignancies from September 2006 to July 2012. To identify all malignancies, the population was linked to the Regional Tumor Registry (RTR). We recorded to which extent a switch to mTOR inhibitors was possible and how often the originally planned oncological managements were adjusted. All patients were followed for three years. (ClinicalTrials.gov: NCT02241564).Results In 76 of 120 patients (63%) a switch to mTOR inhibitors was possible. Immunosuppression was interrupted in seven patients (6%), reduced in three patients (2%) and remained unchanged in 34 of 120 patients (28%). Identification of post-transplant malignancies increased significantly after linkage to RTR (p=0.015). The initially recommended oncological treatment was adjusted in 23 of 44 patients (52%) with solid or hematological malignancies; 36 of these patients (82%) were treated according to national guidelines.Conclusion In two thirds of the patients the immunosuppressive treatment could be changed to an mTOR inhibitor with anti-tumor effects in transplanted patients with post-transplant malignancies. The use of regional tumor registers considerably improved the identification of patients with post-transplant malignancies indicating that post-transplant malignancies might be timely underreported in transplant registers.

Ort, förlag, år, upplaga, sidor
Uppsala: Acta Universitatis Upsaliensis, 2016
Nyckelord
Malignant tumours, Renal transplantation
Nationell ämneskategori
Cancer och onkologi
Forskningsämne
Kirurgi
Identifikatorer
urn:nbn:se:uu:diva-282106 (URN)10.3109/0284186X.2015.1130855 (DOI)000377122300017 ()26824275 (PubMedID)
Tillgänglig från: 2016-04-02 Skapad: 2016-04-01 Senast uppdaterad: 2018-11-16Bibliografiskt granskad
3. Risk factors in the skin for de novo SCC development in renal transplanted recipients with a previous SCC
Öppna denna publikation i ny flik eller fönster >>Risk factors in the skin for de novo SCC development in renal transplanted recipients with a previous SCC
Visa övriga...
(Engelska)Artikel i tidskrift (Refereegranskat) Submitted
Nationell ämneskategori
Medicin och hälsovetenskap
Forskningsämne
Kirurgi
Identifikatorer
urn:nbn:se:uu:diva-282125 (URN)
Tillgänglig från: 2016-04-02 Skapad: 2016-04-02 Senast uppdaterad: 2016-06-01
4. Donor-derived and BK virus positive urologic cancers after renal transplantation
Öppna denna publikation i ny flik eller fönster >>Donor-derived and BK virus positive urologic cancers after renal transplantation
Visa övriga...
(Engelska)Manuskript (preprint) (Övrigt vetenskapligt)
Nationell ämneskategori
Medicin och hälsovetenskap
Forskningsämne
Kirurgi
Identifikatorer
urn:nbn:se:uu:diva-282126 (URN)
Tillgänglig från: 2016-04-02 Skapad: 2016-04-02 Senast uppdaterad: 2018-07-13

Open Access i DiVA

fulltext(1217 kB)313 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1217 kBChecksumma SHA-512
535097bdfc96b6c652a9fbf284fb8a389f6e93ba7a675f9b5fae5ef13347854c052afc5783895560034bdf1886a7950c3cc5548e6ec395c30888a6693cb49a5e
Typ fulltextMimetyp application/pdf
Köp publikationen >>

Sök vidare i DiVA

Av författaren/redaktören
Hellström, Vivan
Av organisationen
Transplantationskirurgi
Medicin och hälsovetenskap

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 313 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

isbn
urn-nbn

Altmetricpoäng

isbn
urn-nbn
Totalt: 1188 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf